Jenburkt Pharmaceuticals Ltd. | Small-cap | Healthcare
₹1,307.35
-0.78%
| Jenburkt Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 1.5B
Gross Profit 1.2B 80.45%
Operating Income 376.6M 24.83%
Net Income 320.6M 21.14%

Balance Sheet Metrics

Total Assets 2.0B
Total Liabilities 244.1M
Shareholders Equity 1.7B
Debt to Equity 0.14

Cash Flow Metrics

Operating Cash Flow 252.8M
Free Cash Flow 81.9M

Revenue & Profitability Trend

Jenburkt Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 1.5B 1.4B 1.4B 1.2B 1.1B
Cost of Goods Sold 296.6M 311.4M 338.1M 320.6M 304.4M
Gross Profit 1.2B 1.1B 1.0B 916.7M 784.3M
Operating Expenses 361.1M 349.4M 336.0M 279.9M 264.7M
Operating Income 376.6M 307.8M 281.1M 253.6M 178.1M
Pre-tax Income 439.3M 351.8M 328.6M 298.7M 216.4M
Income Tax 118.7M 92.0M 82.6M 75.7M 51.4M
Net Income 320.6M 259.8M 246.1M 223.0M 165.0M
EPS (Diluted) - ₹58.86 ₹53.90 ₹48.58 ₹35.96

Income Statement Trend

Jenburkt Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 565.3M 1.1B 810.9M 759.0M 799.9M
Non-Current Assets 1.4B 557.1M 607.6M 670.4M 412.0M
Total Assets 2.0B 1.7B 1.4B 1.4B 1.2B
Liabilities
Current Liabilities 188.2M 163.8M 157.6M 212.8M 179.9M
Non-Current Liabilities 55.9M 37.8M 36.6M 42.9M 47.2M
Total Liabilities 244.1M 201.6M 194.2M 255.7M 227.2M
Equity
Total Shareholders Equity 1.7B 1.4B 1.2B 1.2B 984.7M

Balance Sheet Composition

Jenburkt Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 320.6M 259.8M 246.1M 223.0M 165.0M
Operating Cash Flow 252.8M 31.2M 159.1M 56.1M 209.5M
Investing Activities
Capital Expenditures -197.1M -25.5M -21.0M -25.5M -11.2M
Investing Cash Flow -225.0M -61.1M 10.8M -62.8M -225.9M
Financing Activities
Dividends Paid -67.8M -63.2M -55.0M -46.8M -
Financing Cash Flow -67.8M -63.2M -200.1M -46.8M 1.4M
Free Cash Flow 81.9M 55.7M 149.5M 62.2M 183.1M

Cash Flow Trend

Jenburkt Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 17.88
Forward P/E 37.26
Price to Book 3.34
Price to Sales 3.78
PEG Ratio 37.26

Profitability Ratios

Profit Margin 21.14%
Operating Margin 24.57%
Return on Equity 20.25%
Return on Assets 13.04%

Financial Health

Current Ratio 3.00
Debt to Equity 2.27
Beta 0.41

Per Share Data

EPS (TTM) ₹72.66
Book Value per Share ₹389.23
Revenue per Share ₹343.71

Financial data is updated regularly. All figures are in the company's reporting currency.